Cellectar Biosciences, Inc. — Director's Dealing 2024

Jun 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2024-06-14

Reporting Person: Chanan-Khan Asher (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-14	Stock option (right to buy)	$2.58	A	60000	Acquired	2033-12-22	Common Stock (60000)	Direct

Footnotes

F1: This option was contingently granted on December 22, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 14, 2024.

F2: This option shall vest in full on December 22, 2024, subject to the reporting person's continued service through the applicable vesting date.